Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 439.55
-5.75 (-1.29%)
Sep 11, 2026, 3:30 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 168.41 billion as of September 11, 2026. Its market cap has decreased by -55.53% in one year.
Market Cap
168.41B
Enterprise Value
170.38B
Revenue
21.42B
Ranking
n/a
PE Ratio
158.53
Stock Price
439.55
ChartMarket Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 168.41B, an increase of 499,547.10%. That is a compound annual growth rate of 269.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 168.41B | -16.72% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 372.30B |
| Wockhardt | 365.41B |
| Piramal Pharma | 289.78B |
| Eris Lifesciences | 187.98B |
| Alivus Life Sciences | 170.63B |
| Alembic Pharmaceuticals | 160.47B |
| NATCO Pharma | 148.00B |
| Sudeep Pharma | 144.27B |